Andre G Machado1, Kenneth B Baker, Ela Plow, Donald A Malone. 1. Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Abstract
OBJECTIVES: To review the current state of cerebral stimulation for neuropathic pain and to propose that cerebral stimulation should aim also at the affective sphere of chronic pain rather than solely focusing on the primary sensory-discriminative sphere. METHODS: The past and current goals of cerebral stimulation are reviewed as well as its limitations. A novel deep brain stimulation approach is proposed to evaluate this conceptual shift from somatosensory to affective sphere of pain targeting. APPROACH: Thalamic and other central pain syndromes are typically intractable to current treatment methods, including cerebral neuromodulation of somatosensory pathways, leading to long-term distress and disability. Our modern understanding of chronic pain pathophysiology is based largely on the neuromatrix theory, where cognitive, affective, and sensory-discriminative spheres contribute equally to the overall pain experience. During the last decade, the safety and feasibility of chronic stimulation of neural pathways related to mood and affect has been explored with promising results. Here, we propose a novel approach to modulate the affective sphere of chronic pain by targeting similar networks in patients with treatment-refractory central pain. Our primary goal is not to produce (or measure) analgesia, but rather to modulate the affective burden of chronic pain. DISCUSSION: Cerebral neuromodulation for neuropathic pain has had limited efficacy thus far. Shifting our aim to neural networks related to the affective sphere of pain may allow us to reduce pain conditioning and pain-related disability. Our ultimate goal is to promote rehabilitation from chronic pain-social and occupational.
OBJECTIVES: To review the current state of cerebral stimulation for neuropathic pain and to propose that cerebral stimulation should aim also at the affective sphere of chronic pain rather than solely focusing on the primary sensory-discriminative sphere. METHODS: The past and current goals of cerebral stimulation are reviewed as well as its limitations. A novel deep brain stimulation approach is proposed to evaluate this conceptual shift from somatosensory to affective sphere of pain targeting. APPROACH: Thalamic and other central pain syndromes are typically intractable to current treatment methods, including cerebral neuromodulation of somatosensory pathways, leading to long-term distress and disability. Our modern understanding of chronic pain pathophysiology is based largely on the neuromatrix theory, where cognitive, affective, and sensory-discriminative spheres contribute equally to the overall pain experience. During the last decade, the safety and feasibility of chronic stimulation of neural pathways related to mood and affect has been explored with promising results. Here, we propose a novel approach to modulate the affective sphere of chronic pain by targeting similar networks in patients with treatment-refractory central pain. Our primary goal is not to produce (or measure) analgesia, but rather to modulate the affective burden of chronic pain. DISCUSSION: Cerebral neuromodulation for neuropathic pain has had limited efficacy thus far. Shifting our aim to neural networks related to the affective sphere of pain may allow us to reduce pain conditioning and pain-related disability. Our ultimate goal is to promote rehabilitation from chronic pain-social and occupational.
Authors: Clement Hamani; Jason M Schwalb; Ali R Rezai; Jonathan O Dostrovsky; Karen D Davis; Andres M Lozano Journal: Pain Date: 2006-06-22 Impact factor: 6.961
Authors: Donald A Malone; Darin D Dougherty; Ali R Rezai; Linda L Carpenter; Gerhard M Friehs; Emad N Eskandar; Scott L Rauch; Steven A Rasmussen; Andre G Machado; Cynthia S Kubu; Audrey R Tyrka; Lawrence H Price; Paul H Stypulkowski; Jonathon E Giftakis; Mark T Rise; Paul F Malloy; Stephen P Salloway; Benjamin D Greenberg Journal: Biol Psychiatry Date: 2008-10-08 Impact factor: 13.382
Authors: Raghavan Gopalakrishnan; Richard C Burgess; Scott F Lempka; John T Gale; Darlene P Floden; Andre G Machado Journal: J Neurophysiol Date: 2016-06-29 Impact factor: 2.714
Authors: Vishwanath Sankarasubramanian; David A Cunningham; Kelsey A Potter-Baker; Erik B Beall; Sarah M Roelle; Nicole M Varnerin; Andre G Machado; Stephen E Jones; Mark J Lowe; Ela B Plow Journal: Brain Connect Date: 2017-04
Authors: Andre G Machado; Raghavan Gopalakrishnan; Ela B Plow; Richard C Burgess; John C Mosher Journal: J Neurophysiol Date: 2014-04-30 Impact factor: 2.714
Authors: Kelsey A Potter-Baker; Corin E Bonnett; Patrick Chabra; Sarah Roelle; Nicole Varnerin; David A Cunningham; Vishwanath Sankarasubramanian; Svetlana Pundik; Adriana B Conforto; Andre G Machado; Ela B Plow Journal: J Stroke Cerebrovasc Dis Date: 2016-02-02 Impact factor: 2.136
Authors: Raghavan Gopalakrishnan; Richard C Burgess; Ela B Plow; Darlene P Floden; Andre G Machado Journal: Clin Neurophysiol Date: 2015-12-05 Impact factor: 3.708
Authors: Hyun-Joo Park; Giorgio Bonmassar; James A Kaltenbach; Andre G Machado; Nauman F Manzoor; John T Gale Journal: Nat Commun Date: 2013 Impact factor: 14.919